| Financial Year |
March 31 2023 |
| Monetary Funds |
1,453,926,098.97 |
| Held-for-trading Financial Assets |
653,886,570.94 |
| Notes Receivable |
53,294,349.13 |
| Accounts Receivable |
1,214,540,266.73 |
| Advances to Suppliers |
199,994,184.16 |
| Other Receivables |
166,133,658.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
116,213,237.10 |
| Inventories |
1,423,327,190.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,495,299.23 |
| Total Current Assets |
5,986,004,001.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,266,716.92 |
| Long-term Equity Investment |
297,547,360.55 |
| Investment Properties |
114,548,331.80 |
| Fixed Assetes |
633,828,782.63 |
| Under-construction Projects |
91,545,890.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,289,021.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
54,580,043.43 |
| Deferred Income Tax Assets |
55,787,213.57 |
| Other Non-Current Assets |
16,937,103.33 |
| Sub-Total of Non-Current Assets |
1,505,318,380.04 |
| Total Assets |
7,491,322,381.18 |
| Short-Term Loans |
3,641,598.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
659,190,098.51 |
| Accounts Payable |
863,188,293.23 |
| Accounts Received In Advance |
13,502,112.08 |
| Employee Compensation Payable |
326,595,749.89 |
| Taxes Payable |
54,552,422.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
345,343,425.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,683,704.99 |
| Other Current Liabilities |
108,955,746.78 |
| Sub-Total of Current Liabilities |
3,332,546,148.01 |
| Long-term Loans |
487,850,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,709,737.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
591,318,967.36 |
| Total Liabilities |
3,923,865,115.37 |
| Paid-In Capital(Or Share Stock) |
395,000,000.00 |
| Capital Surplus |
678,217,113.43 |
| Surplus Reserve |
243,259,068.40 |
| LESS:Treasury Stock |
42,915,934.63 |
| Undistributed Profits |
2,285,853,613.58 |
| Minority Stockholder's Interest |
14,862,230.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,552,595,035.57 |
| Owner's Equity（Stockholder's Equity） |
3,567,457,265.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,491,322,381.18 |
